麻豆传媒

Dr. Markovic has developed a robust career in criminal justice, focusing on terrorism particularly focusing on suicide bombings, financing terrorism, and low-tech terrorist attacks such as vehicle-ramming attacks and mass shootings. Upon obtaining her doctoral degree, she became the Director of the Institute for the Study of Violent Groups (ISVG) at Sam Houston State University in Texas where she also served as Principal Investigator on a number of grants. She began her professional career in academia as an assistant professor at the University of New Haven, and eventually became Assistant Dean for the College of Criminal Justice. She has written widely on the topics of suicide terrorism including an op-ed for Forbes Magazine, and a recent publication (2019) in the journal on Women and Criminal Justice Terrorism special issue called 鈥淪uicide Squad: Boko Haram鈥檚 use of the female suicide bomber.鈥�  She is also a regular lecturer for the NATO Center of Excellence 鈥� Defense against Terrorism (COE-DAT) in Ankara, Turkey. She previously worked as a Private Investigator doing corporate due diligence Investigations at Search International.

Dr. Markovic鈥檚 research interests include terrorism, transnational crime, and comparative criminal justice.

Jim Carrington has come a long way since first stepping into a research laboratory as an undergraduate at the University of California, Riverside.

Research in the Carrington lab focuses on RNA-mediated regulation and silencing of genomes, genes and viruses. This lab focuses on the biogenesis, functions, and evolution of small RNA-directed silencing pathways in multicellular eukaryotes. Small RNA-based silencing serves a regulatory mechanism during growth and development and in response to stress. It also functions as a transposon and repeat silencing mechanism, and as an antiviral response in plants and some animals. The Carrington lab uses a combination of genetics, genomics, computation and other approaches to address fundamental mechanistic problems using model systems, but it also seeks to develop tools and approaches that have practical relevance in crop plants. The lab is particularly interested in the underlying mechanisms, including small RNA mechanisms, that govern plant-virus and plant-microbe interactions.

HTS studies in a variety of plants and other organisms have revealed the diversity of ancient and recently evolved miRNA genes, and vast arrays of siRNAs from long dsRNA. The systematic analysis of mutants with defects in miRNA and siRNA function revealed several distinct biogenesis pathways for each class, and target RNAs that are regulated by small RNA families. Distinct small RNA biogenesis and effector components are involved in transcriptional and post-transcriptional silencing systems in plants. They have explored biogenesis, effector and specificity mechanisms of miRNA, trans-acting siRNA (tasiRNA), antiviral siRNA, and other small RNA classes using Arabidopsis thaliana.

Elizabeth Anne Kellogg is an American botanist who now works mainly on grasses and cereals, both wild and cultivated. She earned a Ph.D. from Harvard University in 1983 and was a professor of Botanical Studies at the University of Missouri - St. Louis from September 1998 to December 2013. Since 2013 been a Principal Investigator at the Donald Danforth Plant Science Center in Missouri. In 2020 she was elected a member of the National Academy of Sciences.

Elizabeth has spent her career studying cereal crops and their wild relatives in the grass family, plants on which all of civilization depends. Her unique contribution has been to forge connections between scientists in the front lines of biodiversity research and those breaking new ground in genetic and genomic studies.

The Kellogg lab鈥檚 work identifies deep similarities among plants as apparently disparate as rice, wheat, maize, and the other cereals.  Because similarity and difference are two sides of the same coin, in the process they have also discovered genes that contribute to the diversity of the great cereals of the world.

Members of the Kellogg lab believes that food security is a human right, and that plant scientists have an obligation to contribute to feeding the growing global population.  This is central to the mission of the Center, to 鈥渇eed the hungry and improve human health.鈥� Cereal crops in the grass family 鈥� including rice, maize (corn), wheat, sorghum, barley, and oats 鈥� have fed civilizations for millennia, and are the center of our research.  These crops were selected by humans from an entire ecosystem of wild grasses, which dominate and more than 录 of the land area of the earth. By studying how the wild plants grow, make seeds, and adapt to drought and floods, we can learn how to make more resilient crops.  Conversely, by studying cereal crops, we can predict how wild grasses may adapt to a warmer, drier climate. This aspect of our work reflects the second part of the Center鈥檚 mission, to 鈥減reserve and renew environment.鈥� The third part of the mission is to 鈥渆nhance the St. Louis region as a world center for plant science.鈥�  As you can see in the descriptions of projects below, the lab is a small business supported by grant funding, much of which represents federal tax dollars brought home to Missouri. Like the other labs in the Center, we are an employer, a small business that keeps the economic engine of the city running.

Current projects in the Kellogg lab include:

Adaptation and morphological evolution in the tribe Andropogoneae.  This project is supported by two NSF grants, one of which is producing genomes for as many members of the tribe as possible (see panandropogoneae.com), and the other of which is using those data to investigating evolution of floral and inflorescence structures.
Evolution of grass abscission zones.  We have discovered that the mechanisms controlling how seeds fall off the plant are surprisingly diverse.  This poses mechanistic and evolutionary questions that we are pursuing in wild species and related crops.

With a natural inclination toward math and science in school, Don studied biochemistry at the University of British Columbia, eventually completing a PhD. Since 2018, Don has been the executive director of the Institute for International Crop Improvement (IICI) at the Danforth Center. He manages the IICI鈥檚 programs and partnerships dedicated to translating key discoveries in plant health, disease and pest management, genomics, advanced breeding and nutrition to new solutions for food quality and availability around the globe.

Don鈥檚 team also provides guidance on navigating through the practical, safety, and regulatory processes necessary to demonstrate that new crop varieties are proven safe and effective for the farmers who will benefit from them.

Don is an international expert in regulatory systems for agriculture, including environmental risk assessment, biosafety, and food safety assessments. His extensive experience in plant product development and global regulatory processes aligns with the Institute鈥檚 commitment to collaborate with international and local partner organizations to deliver crops with improved nutritional content and disease resistance to places where people are in most need. In addition to feeding the hungry, these efforts have the potential to contribute to environmental health and empower farmers to become more self-sufficient.

Under Don鈥檚 leadership, the IICI is establishing public-private partnerships to address cross-cutting issues related to environmental and food safety assessment, quality standards, consensus-building, regulatory policy advocacy, and the practical implementation of stewardship best practices for new technologies.

Dr. Rebecca Ellis Dutch is聽a Professor and Chair of the Department of Molecular and
Cellular Biochemistry at the University of Kentucky, and currently leads the COVID-19
Unified Research Experts Alliance team focused on biomedical and clinical issues related to
the pandemic for the university. Becky received a BS in Biochemistry and a BS in
Microbiology from Michigan State University in 1986. As a Churchill Scholar, she then
completed a M.Phil. degree in Biochemistry from Cambridge University, focusing on plant
biochemistry. She received her Ph.D. in Biochemistry from Stanford University in 1994,
working with Dr. I. Robert Lehman on recombination in herpes simplex virus. Becky then
moved to studies of viral glycoproteins in RNA viruses for her postdoctoral training at
Northwestern University/HHMI with Dr. Robert Lamb. She joined the faculty of the University
of Kentucky in 2000. Her research, which has resulted in continuous NIH funding since 2001
and numerous other grants, manuscripts, and presentations focuses on emerging RNA
viruses, with a particular emphasis on viral entry, assembly, and spread.聽 Dr. Dutch was a
2015-2016 University Research Professor in recognition of her outstanding research efforts.
Dr. Dutch teaches at both the undergraduate and graduate level and has twice been named
a finalist for the Provost鈥檚 Outstanding Teacher award. She is also highly committed to the
training and mentoring of young scientists and has served as the primary mentor for 19
Ph.D. students, 4 MD/Ph.D. students, five postdoctoral scholars, and 28 undergraduate
researchers. Dr. Dutch is an editor for Journal of Virology (where she also serves as the
Spotlight editor), Plos Pathogens, and mSphere. She has been a member of numerous grant
review panels, including serving as a standing member of the NIH VIRB and MID study
sections. She also served as the elected President of the American Society for Virology from
2016-2017.

Dr. Ostrosky-Zeichner is a professor of medicine and epidemiology, the chair of the Division of Infectious Diseases, the Vice-Chair of Medicine for Healthcare Quality, and the director of the Laboratory of Mycology Research, at McGovern Medical School (a part of UTHealth Houston). He also serves medical director for epidemiology and antimicrobial stewardship for Memorial Hermann Texas Medical Center and UT Physicians. He also coordinated the CoVID-19 response for UTHealth and its affiliated hospitals and clinics. Dr. Ostrosky-Zeichner obtained his medical degree from Universidad Nacional Autonoma de Mexico. He completed his internal medicine residency at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, and his infectious diseases fellowship at the University of Texas Medical School at Houston and MD Anderson Cancer Center combined fellowship program. Dr. Ostrosky-Zeichner is a fellow of the American College of Physicians, the Infectious Diseases Society of America, the Society of Healthcare Epidemiology of America, and the Academy of the European Confederation of Medical Mycology. He is a Senior Editor for the Journal of Antimicrobial Chemotherapy, as well as an editorial board member of Antimicrobial Agents and Chemotherapy and Clinical Infectious Diseases. He is Vice President of the Mycoses Study Group and Educational Consortium and a Board Member of the International Immunocompromised Host Society. He is also a past chair of the Infectious Diseases Society of America Standards and Practice Guidelines Committee and has been a consultant to the US FDA and CDC. He has advanced training and experience in medical mycology, healthcare epidemiology, emerging infections, antimicrobial stewardship, general and transplant infectious diseases, and healthcare quality and has published over 155 peer-reviewed articles on those topics.

Dr. Michael L. Chang is a pediatric infectious disease specialist in Houston, Texas, and is affiliated with multiple hospitals in the area. His specialty is pediatric infectious diseases and he treats children for a broad array of diseases caused by germs, viruses, and fungi, ranging from flu to hospital-acquired infections to pneumonia. Dr. Chang’s professional interests include antimicrobial stewardship which involves studying and promoting the appropriate, optimal and judicious use of antibiotics for pediatric patients and Carbapenem-resistant Gram-negative bacterial infections.

Cathy Troisi is a professor in the Divisions of Management, Policy, and Community Health and Epidemiology at UTHealth Houston School of Public Health and coordinator for the Leadership Studies Concentration. She teaches courses in leadership and public health and is a faculty advisor for the Society for Women and Leadership. She created and manages the undergraduate public health certificate program. Her research interests are in infectious disease epidemiology, and she has research grants in the areas of HIV, viral hepatitis, and improving immunization rates. She holds a BA in Chemistry from the University of Rochester, an MS in Biochemistry from Michigan State University, and a Ph.D. in Epidemiologic Sciences from the University of Michigan. She completed the National Public Health Leadership Training in February 2011. Previously, she served at the Houston Department of Health and Human Services, where she worked on policy development, research collaborations with academic institutions, promotion of public health education for staff, and preparing for health department accreditation. Prior to that, Cathy was assistant director for the Division of Disease Prevention and Control and prior to that, bureau chief for HIV/STD prevention. Prior to joining HDHHS, she was on the faculty of UTHealth and Baylor College of Medicine. Having experience in both academia and practice, her passion, besides infectious diseases, is bridging the gap between these two essential components of public health. Cathy has been involved with APHA since 2004. She is active in the Epidemiology Section and served as programming chair for two years and Epidemiology Section representative to the Governing Council for seven years. She served as chair of the APHA Action Board and co-chair of the Joint Policy Committee. In the past three years, she has had 15 op-eds published in Texas newspapers and given over 100 media interviews on public health issues. Cathy received the APHA Advocacy award in 2015. She is active with the Texas Affiliate as well, having served on the governing council, and receiving the TPHA award for outstanding service in 2010. She is a member of the National Association of County and City Health Officials epidemiology workgroup as well as many local and state public health advisory boards. 

The research interests of Dr. Boerwinkle encompass the genetic analysis of the common chronic diseases in humans, including coronary artery disease, hypertension, and non-insulin-dependent (type II) diabetes.
Dr. Boerwinkle received his B.S. in Biology from the University of Cincinnati in 1980, an M.A. in Statistics (1984), and M.S. and Ph.D. in Human Genetics (1985) from the University of Michigan, Ann Arbor where he served as Senior Research Associate in the Department of Human Genetics from 1985-1986. He joined the University of Texas-Houston Center for Demographic/ Population Genetics in 1986 as a Research Assistant and became Assistant Professor in the same year. In 1991 he joined the Department of Human Genetics at the School of Public Health, University of Texas-Houston Health Science Center as Associate Professor, in 1996 was promoted to Professor, and in 1997, Director of the Human Genetics Center. He became a faculty member of the Institute of Molecular Medicine in 1996 and became Professor and Director of the Research Center for Human Genetics.

Dr. Boerwinkle is a member of the American Diabetes Association and the American Society of Human Genetics. The research interests of Dr. Boerwinkle encompass the genetic analysis of common chronic diseases in humans, including coronary artery disease, hypertension, and non-insulin-dependent (type II) diabetes. This work includes localizing genes which contribute to disease risk, identification of potentially functional mutations within these genes, testing these candidate functional mutations in experimental systems, defining the impact of gene variation on the epidemiology of the disease, and determining the extent to which these genes interact with environmental factors to contribute to disease risk. Activities include both statistical analysis and laboratory work. A large part of Dr. Boerwinkle's current research effort consists of localizing genes contributing to disease risk using modern genome-wide mapping methods. Success depends on keeping up with the latest genomic technical advances. The laboratory is set-up and operating as a high throughput sequencing and genotyping facility in which speed, accuracy and efficiency are monitored continuously. However, we are constantly seeking out more efficient methods to collect and manage genetic information.

Dr. Boerwinkle and colleagues have completed the world's first genome-wide analyses for a variety of CAD risk factors, including diabetes and hypertension. These investigations have to lead to the identification of novel susceptibility genes in both cases. Dr. Boerwinkle is particularly interested in methods for identifying potentially functional mutations within a gene region. This seemingly simple objective is made difficult because the functional mutations are expected to have small effects and are embedded in a sea of silent genetic variation. Once nearly all of the variation is cataloged directly by DNA sequencing, individuals are genotyped for each variable site. Both novel and traditional statistical methods are applied to relate the array of genetic information to a wealth of phenotypic data. This algorithm generates "candidate functional mutations" that are then tested in an in vitro or mouse model system. Once a functional mutation has been identified, Dr. Boerwinkle's group evaluates the ability of the variable site to predict the onset of disease (e.g. myocardial infarction or stroke) above and beyond traditional risk factors. This work is carried out as part of multiple prospective studies of cardiovascular disease and its risk factors in tens of thousands of individuals representing the major American ethnic groups.

Finally, he is working on experimental designs for studying genotype by environment interaction in humans. In particular, we are working on the extent to which inter-individual variation in lipid-lowering and antihypertensive medications are influenced by genetic factors. The practical objective of the research is to use genetic information to identify individuals at increase risk of disease and to design more efficacious interventions. Genetic studies are defining, at the molecular level, novel mechanisms of disease risk, onset and progression. Dr. Boerwinkle and collaborators address the localization of genes which contribute to disease risk in cardiovascular diseases, hypertension and diabetes. The methodology used involves screening of families having the disease and linking the presence of disease with known markers of the human genome. In this manner, the genomic region in which relevant mutations are located can be mapped and the relevant DNA sequenced. By assessing the structural change the mutation may have caused in the gene product (protein), it is possible to infer how it may affect biological function. In order to determine experimentally whether a mutation is functional, it is necessary to introduce the mutated gene into an animal, usually a mouse, and assess its biological effects on the animal's phenotype.

Dr. Boerwinkle has participated in multiple notable discoveries since joining the Institute. Only two will be highlighted here. First, Dr. Boerwinkle's group has completed the first-ever genome-wide search for genes contributing to inter-individual blood pressure levels. This initial effort has lead to the identification of an important gene (an adrenergic receptor) that influences blood pressure levels and the risk of hypertension. This is the first time that such a genome-wide approach has led to the identification of a susceptibility gene to a major cardiovascular disease risk factor. Second, Dr. Boerwinkle has participated in similar efforts to identify genes contributing to the risk of developing non-insulin-dependent (type II) diabetes. In this case, however, there were no genes in the region that were suspects for the disease. A team of collaborating investigators has painstakingly characterized the genetic region and identified the mutated gene (in this case a protease). This is the first time that anyone has ever positionally cloned a gene contributing to any common chronic disease. This work is of obvious potential clinical importance. It may lead to improved prediction of those at increased risk of disease and the design of more efficacious intervention strategies. The technologies and information from the human genome project provide new tools for lessening the burden of ill-health. Dr. Boerwinkle's accomplishments in developing an internationally recognized team of investigators targeting the genetics of cardiovascular disease and its risk factors ensure a productive future and further discoveries. 

Dr. Sharma is a trained dietitian and physical therapist. As a health professional, she strongly felt she was treating preventable diseases stemming from poor lifestyles: heart disease, diabetes, and hypertension. She saw the repercussions were devastating to the community. Her love for teaching, academics and the community-led her to pursue a Ph.D. in public health, focusing on epidemiology. Her interest is in nutrition and physical activity-based interventions to address obesity via school, family, and the community, predominantly in low-income minority populations. She co-founded Brighter Bites, a partner program of the Houston Food Bank, and serves on the Mayor of Houston’s Go Healthy Houston Task Force. She is currently working on Healthy Eating Active Living (HE/AL). Dr. Sharma explains, “HE/AL is designed to promote healthy birth outcomes and prevent maternally and childhood obesity among low-income Medicaid patients. The project will use evidence-based strategies from Brighter Bites, Legacy of Health, and The Happy Kitchen/La Cocina Alegre to promote breastfeeding and physical activity among pregnant women and women with infants. Families will receive free group education classes (nutrition, cooking, and exercise) and 30 lbs of fresh, seasonal fruits and vegetables weekly for 12 weeks. We will be tracking the effect of the program on maternal weight gain during pregnancy, gestational diabetes, pregnancy-induced hypertension, infant birth weight, breastfeeding, and infant weight gain in the first year of life.”

Philip Stinson, J.D., Ph.D., is a professor of criminal justice at Bowling Green State University. Dr. Stinson鈥檚 primary area of research is police behaviors, including police crime, police corruption, and police misconduct. He is the principal investigator on a research project funded by a grant from the National Institute of Justice (NIJ) at the U.S. Department of Justice to study police crime across the United States. His current research project, Police Integrity Lost: A Longitudinal Study of Police Crime, is supported by the Wallace Action Fund of Tides Foundation. Dr. Stinson鈥檚 research has been published in numerous peer-reviewed journals, including Criminal Justice Policy Review, The Prison Journal, Victims & Offenders, and Journal of Crime & Justice. His research has also been featured in many news publications, including The Washington Post, The Wall Street Journal, The New York Times, and FiveThirtyEight.com. Phil Stinson has appeared on CNN, PBS, NPR, CBC, BBC, Sky 麻豆传媒, CCTV, Radio Sputnik, Democracy Now!, HuffPost Live, and numerous other media outlets worldwide. He teaches a variety of undergraduate and graduate courses at Bowling Green, including Criminal Law, Procedural Rights, Criminal Courts, Criminal Justice Ethics, Criminal Justice Policy Analysis, and Law, Evidence & Procedure in Forensic Science.

Nathaniel Jones, MD, a primary care sports medicine specialist at Loyola Medicine, and the Team Physician for Division 1 Loyola University Chicago, University of St. Francis Joliet, US Soccer. Dr. Jones has more than 14 years of experience. Dr. Nate Jones received his medical degree from the University of Iowa. He completed his residency in Family Medicine at the University of Iowa Hospitals and Clinics and further developed his clinical abilities in the field of Primary Care Sports Medicine by completing a fellowship at the Medical College of Wisconsin, Froedtert Hospital. Certified in sports medicine by the American Board of Family Medicine, he looks after multiple communities in the state of Illinois. Patients visit him to treat a wide variety of sports, musculoskeletal and medical conditions such as sports injuries, arthritis, spondylolysis, tendonitis, osteoarthritis, and sciatica. He is experienced with musculoskeletal ultrasound, joint injections and minor fracture care. He is the Medical Director of the Loyola Concussion Clinic. 
Dr. Jones speaks fluent English, Spanish, and Portuguese. This helps him treat his clients from several cultural backgrounds who are more comfortable to converse with him. His extensive experience in his field of practice has helped him author several publications with other eminent practitioners. He believes in providing excellent patient care and strives towards quickly bringing patients back to their routine way of life. 

Anna Herforth is a senior researcher and consultant specializing in the links between agriculture, food systems and nutrition. She holds a Ph.D. in international nutrition from Cornell University, M.S. in food policy from Tufts University, and a B.S. in plant science from Cornell University. She is currently an adjunct Associate Research Scientist at Columbia University, and a consultant for the UN Food and Agriculture Organization (FAO) and Gallup World Poll on diet quality and food system issues. She has helped shape the agriculture-nutrition conversation globally through working with a wide range of groups, including the World Bank, UN and CGIAR agencies, government aid agencies, nonprofit organizations, and academia. In Africa, South Asia, and Latin America, she has carried out research and spent considerable time with agricultural and indigenous communities. Dr. Herforth is a co-founder of the Agriculture-Nutrition Community of Practice, a professional community with members from over 90 countries.

Dilip joined the Danforth Center on November 1, 2001, the same day that our original building was inaugurated. 鈥淲hen I first came to the Danforth Center, I was suddenly working with PIs that studied plant cell biology, plant structural biology, plant biochemistry. It was really very exciting to have the opportunity to collaborate with them. It was extremely gratifying,鈥� explains Dilip.

Dilip鈥檚 lab studies how plants defend themselves against fungal diseases. The goal of their research is to discover new ways to enable plants to better protect themselves from fungal attacks. To do this, they research antifungal peptides that have the ability to kill pathogens. Once Dilip鈥檚 lab understands how a peptide eliminates a pathogen, his lab can then apply the peptides to make crops resistant to a specific disease. 

One of the fungal diseases that Dilip and his lab are researching is Gray Mold Disease, which causes multi-millions of US dollars in pre- and postharvest losses across the world. Gray mold is caused by a fungus Botrytis cinerea that can infect flowers, fruits, and vegetables. Dilip鈥檚 lab is working on technology that, when applied, could potentially control gray mold in multiple economically important plants. 

Dilip鈥檚 work also has significant implications for the future of food security. In agriculture, 15-20% of crops are lost each year because of the fungal diseases. By making plants more disease resistant, Dilip could reduce that statistic. For a smallholder farmer where each bushel is critical to feeding the community, reducing crop loss could drastically improve human health.

Toni Kutchan serves a vice president for research and is the Oliver M. Langenberg Distinguished Investigator at the Danforth Center where she is investigating two aspects of natural products that are found in plants; how plants produce medicinal natural products at the enzyme and gene level, which could lead to new sources of medications for use against conditions such as dementia and cancer; and the use of plant natural products as components of biofuels.

She is a leading expert in the molecules derived from the opium poppy, including the lifesaving opioid antidote medications. 鈥淧roduction of these drugs creates an industrial waste stream. It鈥檚 not good for the people working in the lab, and it creates a nasty waste pond. We have recently discovered a microorganism that can manufacture opiates in a cleaner, more sustainable way. Now we鈥檙e looking for industrial partners who can help us transform this lab work into an industry process.鈥�

As a recipient of federal research grants, the Danforth Center is prohibited from working on medical cannabis. However, Missouri recently legalized the production of industrial hemp, a crop which was king in Missouri in the late 1800s and which produces high-quality fiber useful in many products, such as textiles, rope, paper, and cosmetics. The Danforth Center and the Kutchan Lab are already forming partnerships. 鈥淲ith the cutting-edge technology and infrastructure at the Danforth Center, we can accelerate the breeding and help reestablish this useful cash crop in the state of Missouri. Hemp has been illegal for 100 years. We are now attempting to go from zero to introducing a modern crop.鈥�
 
Prior to joining the Center in 2006, she spent 20 years researching biochemistry at the University of Munich and the Leibniz Institute of Plant Biology.  In recognition of her scientific achievements, Toni was elected Fellow of the American Association for the Advancement of Science in 2017 and the prestigious German Academy of Sciences (Leopoldina) in 2010. She received her doctorate in biochemistry from Saint Louis University and a bachelor鈥檚 degree in chemistry from the Illinois Institute of Technology.
 
Toni credits training the next generation of scientists as a very rewarding part of her work at the Danforth Center and adds: 鈥淭raining the up-and-coming generations is so important, making sure they have broad interests and perspective. Together, we can make the world a better place, safer, more sustainable. By unlocking the secrets of plants, we will make peoples鈥� lives better鈥攁nd that鈥檚 a good feeling.鈥�
 

Kirk is an internationally renowned expert in bioimaging with 30 years鈥� experience and over 100 publications. He is proud of his role in discovering a new imaging approach to follow subcellular calcium signaling in filamentous fungi鈥攁 world first. His research today focuses on small microbes that cause disease in both humans and plants. And he is dedicated to his role at the Danforth Center, partnering with numerous colleagues to help advance their research as well.
 
In 2019, Kirk joined the Donald Danforth Plant Science Center as a principal investigator and director of the Advanced Bioimaging Laboratory Facility, to leverage advanced microscopy tools in plant science dedicated to producing more nutritious food and improving the environment. With over 30 years of advanced microscopy experience, Dr. Czymmek has expertise in most forms of light, X-ray, and electron microscopy, atomic force microscopy, single-molecule imaging, superresolution microscopy, cryotechniques, and correlative microscopy. His work on developing and applying cutting-edge microscopy tools for imaging cells, tissues, and biomaterials has generated over 95 refereed publications.

Prior to joining the Danforth Center, Kirk served as Vice President of Global ZEISS Microscopy Customer Centers and oversight of eight customer centers and their teams worldwide. He joined the company in 2012 to build a world-class application, demonstration, and training center for the ZEISS microscopy portfolio for North America. From 2000 to 2012 he was an Associate Professor in the Department of Biological Sciences at the University of Delaware (UD) where he worked to build an imaging capacity that led in 2001 to the creation of the UD Bio-Imaging Center at the Delaware Biotechnology Institute, where he served as Director.

Kirk received his doctorate in the Department of Botany and Plant Pathology at Michigan State University in 1993 followed by a post-doctoral position at the DuPont Company in CR&D Plant Molecular Genetics group. Subsequently, he worked with Noran Instruments in the confocal business group as an applications scientist before joining the University of Delaware.  He has received many awards and honors for his achievements in the field.

Dr. Amy Moore is the Director of Science and Research at GO2 Foundation. Dr. Amy C. Moore is a PhD-trained virologist and cancer researcher and has spent over a decade working on large statewide and multi-institution initiatives in cancer and vaccines. She currently serves as Director of Science & Research for the GO2 Foundation for Lung Cancer and also works closely with GO2 Foundation's sister organization, the Addario Lung Cancer Medical Institute (ALCMI), to build research capacity in emerging areas of concern to the lung cancer community.  

Because of her virology training and position as a leader in the advocacy community, Dr. Moore has become a highly sought-after expert to discuss the intersection of lung cancer and COVID-19. Since early March, she has participated in over half a dozen panel discussions, webinars, and interviews with leading groups such as IASLC, CURE, US 麻豆传媒 & World Report to discuss the threat COVID-19 presents to patients with lung cancer and how we can mobilize research to understand this risk. 

Chief Patient Officer at GO2 Foundation for Lung Cancer and has been working in lung cancer non-profit for the past 11 years. She is responsible for all aspects of patient programming, services, engagement, and empowerment along with strategic insight and planning around lung cancer awareness and education.  Through personal history with lung cancer, Bonnie Addario is her mother, she has had hands-on experience as a caregiver as it relates to lung cancer the disease, treatments, the emotional and physical experience along with experience through survivorship. 

She has developed multiple patient education programs and educational publications that have reach in 143 countries around the world. In her role, she directly touches patients, caregivers, physicians, nurses, and industry professionals. She attends scientific meetings specific to lung cancer, has sat on multiple advisory boards and has experience with speaking engagements across the lung cancer community. 

Diana D鈥橝mico Pawlewicz, Ph.D., a historian of education and social policy, is an assistant professor in the Educational Foundations and Research Program at the University of North Dakota supported by the Elnora Danley Professorship. Dr. D鈥橝mico Pawlewicz鈥檚 research explores school policy as social policy and centers on fundamental questions around equity, race, power, and the role of institutions in creating or disrupting inequality. Dr. D鈥橝mico Pawlewicz strives to construct her historical scholarship upon an interdisciplinary foundation that draws upon sociology, economics, gender studies, and critical race theory. Through her scholarship and teaching, Dr. D鈥橝mico Pawlewicz envisions herself as a bridge builder connecting (1) history to disciplines across the university, (2) the past to the present, and (3) the university to the public. Specifically, Dr. D鈥橝mico Pawlewicz鈥檚 research explores the history of the public school workforce and the creation and maintenance of racialized ideas, policies, and practices. Her work has appeared in the Washington Post, History of Education Quarterly, Harvard Educational Review, Labor: Studies in Working Class History, American Educational Research Journal, and several other outlets.

Dr. D鈥橝mico Pawlewicz鈥檚 first book, Blaming Teachers: Professionalization Policies and the Failure of Reform in American History, will be out in August of 2020. She is also editing a volume entitled Walkout: Teacher Militancy, Activism, and School Reform to be published by IAP and conducting research for her third book, tentatively titled Pathologizing Blackness: The National Teacher Corps, Federal Education Policy, and the Politics of Race and Achievement.

Dr. D鈥橝mico Pawlewicz earned her Ph.D. from New York University where she was a Spencer Dissertation Fellow and received the Politics of Education Association鈥檚 Outstanding Dissertation Award. After earning her degree, she spent a post-doctoral year as a visiting assistant professor at Brown University. Before arriving at UND, Dr. D鈥橝mico Pawlewicz was assistant professor at George Mason University where she served as Professor-in-Charge of the Education Policy Doctoral Specialization and was named a University Teacher of Distinction.  

Dr. Brent Goldfarb is an Associate Professor of Management and Entrepreneurship in the M&O Department at the University of Maryland's Robert H. Smith School of Business. Goldfarb's research focuses on how the production and exchange of technology differs from more traditional economic goods, with a focus on the implications on the role of startups in the economy. He focuses on such questions as how do markets and employer policies affect incentives to discover new commercially valuable technologies and when is it best to commercialize them through new technology-based firms? Why do radical technologies appear to be the domain of startups? And how big was the dot.com boom? Copies of Dr. Goldfarb's publications and working papers have been downloaded over 1200 times.